China Resources Double-Crane Pharmaceutical Co.,Ltd. Revenue

China Resources Double-Crane Pharmaceutical Co.,Ltd. had revenue of 2.62B CNY in the quarter ending September 30, 2024, with 0.55% growth. This brings the company's revenue in the last twelve months to 10.32B, down -5.44% year-over-year. In the year 2023, China Resources Double-Crane Pharmaceutical Co.,Ltd. had annual revenue of 10.22B with 6.20% growth.

Revenue (ttm)

10.32B

Revenue Growth

-5.44%

P/S Ratio

1.93

Revenue / Employee

841.30K

Employees

12,269

Market Cap

19.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	10.22B	596.82M	6.20%
Dec 31, 2022	9.63B	513.80M	5.64%
Dec 31, 2021	9.11B	607.58M	7.14%
Dec 31, 2020	8.50B	-877.05M	-9.35%
Dec 31, 2019	9.38B	1.16B	14.05%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Shanghai United Imaging Healthcare	10.93B
Yunnan Baiyao Group Co.,Ltd	39.34B
Beijing Wantai Biological Pharmacy Enterprise	2.49B

Revenue Rankings